Eris Lifesciences Share Price

₹ 1,178.40

+₹18.20 (1.57%)
1D
Last updated 03 Nov, 2026, 15:29 IST
NSE: ERIS
|
Pharmaceuticals

Eris Lifesciences Share Price Today

As of 3 Nov 2026, Eris Lifesciences share price is ₹1,178.40. The stock opened at ₹1,162.10, compared to its previous close of ₹1,160.20. During today's trading session, Eris Lifesciences share price moved in the range of ₹1,159.30 to ₹1,183.00, with an average price of ₹1,171.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,069.00 and a high of ₹1,740.00.

Share price over the last 1 day rose from 1164.80 to 1178.40, ranging between 1162.80 and 1180.20.
₹1,159.30
1.57% up today
₹1,183.00
1D LOW
1D HIGH

Eris Lifesciences Stock Insights

Latest Earning
Op Profit TrendUp by 12.60% QoQ
Latest Earning
Net Profit TrendUp by 72.82% YoY
Latest Earning
Revenue TrendUp by 15.40% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 19.1 % in last 1 yr
Shareholding Pattern
PromoterPromoter increased stake by 1.11%
Shareholding Pattern
DIIDII increased stake by 20.64%
Shareholding Pattern
FIIFII decreased stake by 0.18%
Eris Lifesciences stock performance
Open₹1,162.10
High₹1,183.00
Low₹1,159.30
Prev. close₹1,160.20
Eris Lifesciences trading activity
Volume1,50,925
Average traded price₹1,171.82
Last traded time03:29:56 03 Nov
Last traded quantity1
Circuit
L
H
₹928.20
₹1,392.20
52-week
L
H
₹1,069.00
₹1,740.00
Mkt Cap Cr
16,088.12
P/E
22.47
P/B
3.89
ROA
9.48%
ROE
17.07%
ROCE
12.58%
Quick Ratio
0.53
EV/EBITDA
16.37

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
ERIS Lifescience has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
ERIS Lifescience appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
ERIS Lifescience revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Eris Lifesciences Company Background

ISIN
INE406M01024
Sector Market Cap
₹ 16,088.12 Cr

Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD), and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women’s health, central nervous system (CNS), oncology, and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.

Eris Lifesciences Financial Highlights

  • Revenue: Eris Lifesciences reported revenue of ₹3,137.17 crore in FY26 vs ₹2,912.00 crore in FY25. It showed an increase of 7.73% on a yearly basis.
  • Operating Profit: Eris Lifesciences reported an operating profit of ₹638.54 crore in FY26 vs ₹488.87 crore in FY25. It showed an increase of 30.62% on a year-on-year basis.
  • Net Profit: Eris Lifesciences reported a net profit of ₹647.51 crore in FY26 vs ₹374.67 crore in FY25. It showed an increase of 72.82% on a yearly basis.

Eris Lifesciences Quarterly Result Highlights

  • Eris Lifesciences reported revenue of ₹875.64 crore in Jun 2026, compared with ₹758.79 crore in Mar 2026, representing an increase of 15.40% on a quarter-on-quarter (QoQ) basis.
  • Eris Lifesciences reported an operating profit of ₹179.49 crore in Jun 2026, compared with ₹159.41 crore in Mar 2026, representing an increase of 12.60% on a quarter-on-quarter (QoQ) basis.
  • Eris Lifesciences reported a profit of ₹143.32 crore in Jun 2026, compared with ₹279.10 crore in Mar 2026, reflecting a decrease of 48.65% on a QoQ basis.
  • The earnings per share (EPS) of Eris Lifesciences stood at ₹45.33 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
54.74%
FII
5.74%
Other DII
2.22%
Retail and other
19.32%
Mutual funds
17.98%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20256.85%
Mar 20266.39%
Jun 20265.75%
Sep 20265.74%

Eris Lifesciences Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

Eris Lifesciences Share Price History

Eris Lifesciences share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1,160.00 / ₹1,160.20
+0.33%
30 Oct 26
₹1,163.00 / ₹1,156.40
-0.62%
29 Oct 26
₹1,170.20 / ₹1,163.60
-1.00%
28 Oct 26
₹1,215.00 / ₹1,175.40
-1.92%
Show more

Eris Lifesciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,129.42₹2,893.64₹2,009.15₹1,685.15
Other Income₹7.75₹18.36₹23.82₹11.15
Total Revenue₹3,137.17₹2,912.00₹2,032.97₹1,696.30
Total Expenses₹2,481.48₹2,423.19₹1,601.63₹1,291.66
Profit Before Tax₹638.54₹488.87₹431.34₹404.64
Tax-₹8.97₹114.20₹34.22₹30.48
Profit After Tax₹647.51₹374.67₹397.12₹374.16
EPS - Basic₹45.33₹25.85₹28.82₹28.10
EPS - Diluted₹45.26₹25.81₹28.79₹28.07

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹638.54₹488.87₹431.34₹404.64
Income before WC changes₹1,120.40₹1,036.92₹685.50₹544.48
Change in Assets-₹414.08₹15.99-₹90.25-₹188.85
Change in Liabilities-₹43.95₹109.98-₹8.49₹13.32
Change in WC-₹458.03₹125.97-₹98.74-₹175.54
Cash flow from Operations₹537.99₹1,065.01₹486.01₹291.74
Cash flow from Investing-₹369.46-₹79.97-₹1,854.52-₹982.10
Cash flow from Financing-₹313.53-₹881.32₹1,379.78₹688.03
Total Cash Flow-₹145.00₹103.72₹11.27-₹2.34
Cash (Start of the year)₹199.74₹94.25₹56.02₹50.87
Cash (End of the year)₹54.74₹199.74₹94.15₹56.02

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹5,825.66₹5,810.18₹4,738.42₹2,902.61
Current Assets₹1,539.85₹1,226.23₹2,302.04₹764.72
Total Assets₹7,365.51₹7,036.41₹7,040.46₹3,667.33
Current Liabilities₹2,077.10₹1,384.63₹2,532.07₹443.23
Net Current Asset-₹537.25-₹158.40-₹230.03₹321.49
Non-Current Liabilities₹1,392.75₹2,380.02₹1,286.30₹1,003.42
Equity Capital₹3,895.66₹3,271.76₹3,222.09₹2,220.68
Total Equity & Liabilities₹7,365.51₹7,036.41₹7,040.46₹3,667.33

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,821.74₹1,697.75₹1,486.71₹1,330.73
Other Income₹98.31₹35.51₹34.83₹17.26
Total Revenue₹1,920.05₹1,733.26₹1,521.54₹1,347.99
Total Expenses₹1,543.33₹1,613.21₹1,192.70₹911.08
Profit Before Tax₹362.05₹120.05₹328.84₹436.91
Tax₹118.00₹42.66₹29.12₹38.90
Profit After Tax₹244.05₹77.39₹299.72₹398.01
EPS - Basic₹17.86₹5.69₹22.04₹29.27
EPS - Diluted₹17.83₹5.68₹22.01₹29.23

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹362.05₹120.05₹328.83₹436.91
Income before WC changes₹625.22₹513.61₹472.95₹510.61
Change in Assets₹38.19₹117.87-₹102.33-₹122.00
Change in Liabilities-₹24.54₹83.82₹39.15₹11.50
Change in WC₹13.65₹201.69-₹63.18-₹110.50
Cash flow from Operations₹563.94₹701.87₹336.29₹322.33
Cash flow from Investing-₹694.16-₹358.99-₹2,491.89-₹513.30
Cash flow from Financing₹71.06-₹310.47₹2,160.05₹193.75
Total Cash Flow-₹59.16₹32.41₹4.45₹2.78
Cash (Start of the year)₹84.34₹51.93₹47.48₹44.70
Cash (End of the year)₹25.18₹84.34₹51.93₹47.48

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹4,755.13₹4,594.89₹3,473.03₹2,231.58
Current Assets₹1,022.81₹627.54₹1,876.54₹552.08
Total Assets₹5,777.94₹5,222.43₹5,349.57₹2,783.66
Current Liabilities₹1,717.73₹993.94₹2,261.79₹283.77
Net Current Asset-₹694.92-₹366.40-₹385.25₹268.30
Non-Current Liabilities₹864.75₹1,713.59₹563.76₹278.00
Equity Capital₹3,195.46₹2,514.90₹2,524.02₹2,221.88
Total Equity & Liabilities₹5,777.94₹5,222.43₹5,349.57₹2,783.66
* All values are in INR Crore
Eris Lifesciences market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Eris Lifesciences technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
45.15
Neutral
ATR (14)
39.46
Neutral
STOCH(9,6)
62.25
Neutral
STOCH RSI (14)
77.65
Neutral
ADX(9)
35.2
Bearish
UO(9)
46.4
Neutral
ROC(12)
0.92
Bullish
WillR(14)
-37.75
Neutral
Period
Simple value
Exponential vaue
5D
1170.8
1157.99
10D
1143.26
1154.42
20D
1151.36
1167.06
50D
1238.28
1225.93
100D
1324.98
1280.71
Volume trend — traded volume by day
3 Nov1L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct7L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Eris Lifesciences
Pharmaceuticals
Add Stock
Add Another

Eris Lifesciences Returns Calculator

Ex-date: 29 May 2026

Eris Lifesciences Latest News

1 month ago
Honasa Consumer, EIH, NCC shares spurt amid spike volumes; check full list
Showing news item 1 of 1

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

Eris Lifesciences Share Price FAQs

Please be aware that Eris Lifesciences stock prices are subject to continuous fluctuations due to various factors.